Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Western Blot: MERS-CoV Nucleoprotein Antibody [NBP3-16057] - Analysis of extracts of MERS-CoV Nucleoprotein, using MERS-CoV Nucleoprotein antibody (NBP3-16057) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 0.5s.](http://images.novusbio.com/fullsize/MERS-CoV-Nucleoprotein-Antibody-Western-Blot-NBP3-16057-img0001.jpg "Western Blot: MERS-CoV Nucleoprotein Antibody [NBP3-16057] - Analysis of extracts of MERS-CoV Nucleoprotein, using MERS-CoV Nucleoprotein antibody (NBP3-16057) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 0.5s.")
![ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - No cross-reactivity in ELISA with MERS-CoV Nucleoprotein protein and SARS Coronavirus Nucleocapsid.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-ARC5077-02-Azide-and-BSA-Free-ELISA-NBP3-05765-img0002.jpg "ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - No cross-reactivity in ELISA with MERS-CoV Nucleoprotein protein and SARS Coronavirus Nucleocapsid.")
![ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-ARC5077-02-Azide-and-BSA-Free-ELISA-NBP3-05765-img0001.jpg)
![Western Blot: SARS Nucleocapsid Protein Antibody (14B3D) [NBP3-07063] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid protein, Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [14B3D], NBP3-07063, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-Nucleocapsid-Protein-Antibody-14B3D-Western-Blot-NBP3-07063-img0001.jpg "Western Blot: SARS Nucleocapsid Protein Antibody (14B3D) [NBP3-07063] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid protein, Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [14B3D], NBP3-07063, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![ELISA: SARS-CoV-2 Nucleocapsid Antibody (84D7) [NBP3-07042] - Microtiter wells were coated with SARS-CoV-2 Nucleocapsid and SARS-CoV Nucleocapsid at 1 ug/ml. Purified rabbit monoclonal antibodies were serially diluted 1:2 starting at 1 ug/ml, which show very strong and specific binding to SARS-CoV-2 Nucleocapsid antigen, with no significant cross-reactivity to SARS-CoV Nucleocapsid antigen.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-84D7-ELISA-NBP3-07042-img0001.jpg "ELISA: SARS-CoV-2 Nucleocapsid Antibody (84D7) [NBP3-07042] - Microtiter wells were coated with SARS-CoV-2 Nucleocapsid and SARS-CoV Nucleocapsid at 1 ug/ml. Purified rabbit monoclonal antibodies were serially diluted 1:2 starting at 1 ug/ml, which show very strong and specific binding to SARS-CoV-2 Nucleocapsid antigen, with no significant cross-reactivity to SARS-CoV Nucleocapsid antigen.")
![Sandwich ELISA: SARS-CoV-2 Nucleocapsid Antibody (84D7) [NBP3-07042] - A sandwich ELISA was performed using SARS-CoV-2 Nucleocapsid specific rabbit monoclonal antibodies: capture antibody and biotin-labeled as a detection antibody. SARS-CoV-2 Nucleocapsid was serially diluted 1:2 starting at 25 ng/ml. Rabbit monoclonal antibodies capture antibody and biotin-labeled antibodies detected SARS-CoV-2 Nucleocapsid antigen at very high sensitivity as low as 25 pg/ml (25 pg).](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-84D7-Sandwich-ELISA-NBP3-07042-img0002.jpg)
![Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8) [NBP3-05729] - Validation of SARS-CoV-2 Nucleocapsid AntibodyLane 1: 50ng, Lane 2: 25ng, Lane 3: 5ng, Lane 4: 2ng , Lane 5: 1ng and Lane 6: 0.5ng of SARS-CoV-2 N protein probed with SARS-CoV-2 Nucleocapsid Antibody [6A8], at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-6A8-Western-Blot-NBP3-05729-img0001.jpg "Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8) [NBP3-05729] - Validation of SARS-CoV-2 Nucleocapsid AntibodyLane 1: 50ng, Lane 2: 25ng, Lane 3: 5ng, Lane 4: 2ng , Lane 5: 1ng and Lane 6: 0.5ng of SARS-CoV-2 N protein probed with SARS-CoV-2 Nucleocapsid Antibody [6A8], at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![Western Blot: SARS Nucleocapsid Protein Antibody (8G8A) [NBP3-07064] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid Protein and Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [8G8A], NBP3-07064, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-Nucleocapsid-Protein-Antibody-8G8A-Western-Blot-NBP3-07064-img0001.jpg "Western Blot: SARS Nucleocapsid Protein Antibody (8G8A) [NBP3-07064] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid Protein and Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [8G8A], NBP3-07064, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![ELISA: SARS-CoV-2 Nucleocapsid - Omicron Variant, B.1.1.529 ELISA Kit (Colorimetric) [NBP3-21465] - Standard curve reference](http://images.novusbio.com/fullsize/nbp3-21465_sars-cov-2-nucleocapsid-omicron-b-1-1-529-elisa-kit-color-1612025225170.png "ELISA: SARS-CoV-2 Nucleocapsid - Omicron Variant, B.1.1.529 ELISA Kit (Colorimetric) [NBP3-21465] - Standard curve reference")